Genomic amplification of CCND2 is rare in non-Hodgkin lymphomas

Cancer Genetics and Cytogenetics

Volumn 102, Issue 1, 1998, Pages 81-82

  Andreasson, Patrik ^a   Johansson, Bertil ^a   Arheden, Kristina ^a   Kristoffersson, Ulf ^a   Åkerman, Måns ^a   Mitelman, Felix ^a   Höglund, Mattias ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BURKITT LYMPHOMA; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENOME; HUMAN; HUMAN CELL; LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 12; CYCLINS; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, NON-HODGKIN;

EID: 0032054435     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(97)00291-4     Document Type: Article

References (11)

1. Kamb A (1995): Cell-cycle regulators and cancer. Trends Genet 11:136-140.
2. Peters G (1994): The D-type cyclins and their role in tumorigenesis. J Cell Sci Suppl 18:89-96.
3. 1 regulation in human head and neck cancer. Cancer Res 55:949-956.
4. Palmero I, Holder A, Sinclair AJ, Dickson C, Peters G (1993): Cyclins D1 and D2 and differentially expressed in human B-lymphoid cell lines. Oncogene 8:1049-1054.
5. Dreyling MH, Bohlander SK, Le Beau MM, Olopade OI (1995): Refined mapping of genomic rearrangements involving the short arm of chromosome 9 in acute lymphoblastic leukemias and other hematologic malignancies. Blood 86:1931-1938.
6. Leach FS, Elledge SJ, Sherr CJ, Willson JKV, Markowitz S, Kinzler KW, Vogelstein B (1993): Amplification of cyclin genes in colorectal carcinomas. Cancer Res 53:1986-1989.
7. Delmer A, Ajchenbaum-Cymbalista F, Tang R, Ramond S, Faussat AM, Marie JP, Zittoun R (1995): Overexpression of cyclin D2 in chronic B-cell malignancies. Blood 85:2870-2876.
8. Höglund M, Johansson B, Pedersen-Bjergaard J, Marynen P, Mitelman F (1996): Molecular characterization of 12p abnormalities in hematologic malignancies: Deletion of KIP1, rearrangement of TEL, and amplification of CCND2. Blood 87:324-330.
9. Andreasson P, Johansson B, Arheden K, Billström R, Mitelman F, Höglund M (1997): Deletions of CDKN1B and ETV6 in acute myeloid leukemia and myelodysplastic syndromes without cytogenetic evidence of 12p abnormalities. Genes Chromosom Cancer 19:77-83.
10. Golub TR, Barker GF, Stegmaier K, Gilliland DG (1996): Involvement of the TEL gene in hematologic malignancies by diverse genetic mechanisms. Curr Top Microbiol Immunol 211:279-288.
11. Wlodarska I, Baens M, Peeters P, Aerssens J, Mecucci C, Brock P, Marynen P, Van den Berghe H (1996): Biallelic alterations of both ETV6 and CDKN1B genes in a t(12;21) childhood acute lymphoblastic leukemia case. Cancer Res 56:2655-2661.